Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS
- 1 April 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 17 (4) , 527-534
Abstract
Background and objectives: Patients with monoclonal gammopathy and concomitant kidney diseases are frequently found in clinical practice. Some of them are diagnosed with monoclonal gammopathy of renal significance (MGRS) due to the presence of monoclonal Ig–related kidney injuries. This study aimed to investigate the histopathologic spectrum and clinical characteristics associated with MGRS in a large cohort of patients with monoclonal gammopathy and biopsy-proven kidney diseases from a single Chinese nephrology referral center. Design, setting, participants, & measurements: Patients who presented with monoclonal gammopathy (monoclonal spike on serum and/or urine immunofixation tests) and underwent kidney biopsy in the Peking University First Hospital from January 1, 1999 to December 31, 2020 were enrolled in this retrospective study. Patients with malignant hematologic diseases were excluded. Clinical and laboratory data were collected from the electronic medical record system. Comparisons of patients with and without MGRS and with and without amyloidosis were performed. The clinical characteristics associated with MGRS were identified using multivariable logistic regression. Results: A total of 700 patients with monoclonal gammopathy and kidney biopsy were identified. Thirteen patients with repeat kidney biopsies were analyzed separately. For the remaining 687 patients with one kidney biopsy, 261 patients (38%) had MGRS lesions, and the rest (426 patients, 62%) had non-MGRS kidney diseases. Ig-related amyloidosis accounted for the most MGRS cases (n=164, 63%), followed by monoclonal Ig deposition disease (n=23, 9%) and thrombotic microangiopathy (n=22, 8%). In the non-MGRS group, membranous nephropathy was the most common diagnosis (n=171, 40%). In the multivariable logistic regression model, the presence of abnormal serum free light chain ratio, older age, and greater proteinuria were independently associated with MGRS. Conclusions: Monoclonal Ig amyloidosis is the leading cause of MGRS in Chinese patients with monoclonal gammopathy. The presence of abnormal free light chain ratio, older age, and greater proteinuria were associated with MGRS.Keywords
Funding Information
- National Natural Science Foundation of China (No. 81470956, No. 81500543)
This publication has 22 references indexed in Scilit:
- Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-AnalysisPLOS ONE, 2016
- Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in ChinaJournal of the American Society of Nephrology, 2016
- How I treat monoclonal gammopathy of renal significance (MGRS)Blood, 2013
- Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and preventionThe Lancet, 2013
- Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificantBlood, 2012
- Differential diagnosis of monoclonal gammopathy of undetermined significance.Hematology-American Society Hematology Education Program, 2012
- Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and managementLeukemia, 2010
- Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2008
- Prevalence of Monoclonal Gammopathy of Undetermined SignificanceNew England Journal of Medicine, 2006
- Monoclonal gammopathy of undetermined significanceThe American Journal of Medicine, 1978